Skip to main content
OpenTrials
Completed

NCT Number: NCT00762437

Non-Invasive Cooling of Fat Cells

The purpose of this study is to evaluate a non-invasive cooling device to determine if cold exposure will consistently result in a reduction of subcutaneous fat.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Investigational Site, Sacramento, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female subjects > 18 years of age.
  • Subject has clearly visible fat on an area of the body appropriate for treatment with the non-invasive Zeltiq cooling device such as the flanks, thighs, abdomen or back.
  • Subject has not had weight change fluctuations exceeding 10 pounds in the preceding month and plans to maintain their weight to within ±10 pounds over the next 6 months.
  • Subject has read and signed a written informed consent form.

Exclusion criteria

  • Subject has had liposuction, or another surgical procedure(s) or mesotherapy in area of intended treatment within the past 2 years.
  • Subject has a known history of subcutaneous injections into the area of intended treatment (e.g., cortisone) within the past 6 months.
  • Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal cold hemoglobinuria.
  • Subject has used diet pills within the past 6 months.
  • Subject is unable or unwilling to comply with the study requirements.
  • Subject has any dermatological conditions or scars within the location of the test sites that may interfere with the treatment or evaluation.
  • Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device.
  • Patient is pregnant or intending to become pregnant in the next 9 months.
  • Patient is lactating or has been lactating in the past 9 months.
  • Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect response or participation in this clinical study, or would pose an unacceptable risk to the subject.

Treatment and study plan

Zeltiq Dermal Cooling Device

Device

Non-invasive cooling is applied to the treatment area with a defined cooling rate and duration.

Primary outcomes

  1. Percentage of Participants With Visible Improvement in Treated Area

    Time frame: 4 months

    Investigator assessment to document any visible improvement in the treatment area.

Secondary outcomes

  1. Participant Satisfaction

    Time frame: 4 months

    Percentage satisfaction with the Zeltiq procedure as determined by the results of a subjects satisfaction questionnaire.

Sponsors and collaborators

Lead sponsor

Zeltiq Aesthetics

Industry

Registry information

Official study title

A Prospective Clinical Study of Non-Invasive Cooling of Subcutaneous Fat

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Sep 30, 2008
Registry last updated
May 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.